Review



hiscript iii rt supermix for qpcr  (Vazyme Biotech Co)


Bioz Verified Symbol Vazyme Biotech Co is a verified supplier
Bioz Manufacturer Symbol Vazyme Biotech Co manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 99

    Structured Review

    Vazyme Biotech Co hiscript iii rt supermix for qpcr
    Hiscript Iii Rt Supermix For Qpcr, supplied by Vazyme Biotech Co, used in various techniques. Bioz Stars score: 99/100, based on 10780 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/iii/HiScript+III+RT+SuperMix+for+qPCR+%2BgDNA+wiper/pm42908380-364-14-22
    Average 99 stars, based on 10780 article reviews
    hiscript iii rt supermix for qpcr - by Bioz Stars, 2026-11
    99/100 stars

    Images

    Related Articles

    Synthesized:

    Article Title: A Mitochondria-Modulating Nanosystem for Rheumatoid Arthritis Immunotherapy via Inflammatory Cascade Disruption.
    Article Snippet: Rheumatoid arthritis (RA) is a systemic autoimmune disease characterized by chronic inflammation within joints, where macrophage-driven inflammatory cascade caused by mitochondrial dysfunction significantly contributes to the pathogenesis.. Through recruitment and activation of neutrophils from circulation, these macrophages promote the release of neutrophil extracellular traps (NETs) and generation of reactive oxygen species (ROS), leading to synovitis exacerbation and tissue damage.. To disrupt this closely linked cycle, we present a mitochondria-modulating nanosystem (NM@APDAase) targeting the inflammatory cascade for RA immunotherapy.

    Article Title: CREBBP loss drives immune evasion by epigenetically silencing STING and MHC-I in small cell lung cancer.
    Article Snippet: Total RNA was extracted from tumor cells using TRIzol reagent (15596026CN, ThermoFisher). .. cDNA was synthesized using HiScript III All- in- one RT SuperMix (R333–01, Vazyme). .. Quantitative PCR was performed with ChamQ Universal SYBR qPCR Master Mix (Q711–02, Vazyme).

    Real-time Polymerase Chain Reaction:

    Article Title: A Mitochondria-Modulating Nanosystem for Rheumatoid Arthritis Immunotherapy via Inflammatory Cascade Disruption.
    Article Snippet: Rheumatoid arthritis (RA) is a systemic autoimmune disease characterized by chronic inflammation within joints, where macrophage-driven inflammatory cascade caused by mitochondrial dysfunction significantly contributes to the pathogenesis.. Through recruitment and activation of neutrophils from circulation, these macrophages promote the release of neutrophil extracellular traps (NETs) and generation of reactive oxygen species (ROS), leading to synovitis exacerbation and tissue damage.. To disrupt this closely linked cycle, we present a mitochondria-modulating nanosystem (NM@APDAase) targeting the inflammatory cascade for RA immunotherapy.

    Flow Cytometry:

    Article Title: The lumpy skin disease virus protein LSDV003 regulates MHC-I trafficking and surface expression.
    Article Snippet: .. Reagents included TrypLE Express (12604021, ThermoFisher Scientific); EDTA (10 mM, pH 8.0; BL518A, Biosharp); Flow Cytometry Perm Buffer (PF00017, Proteintech); RNAiso Plus (#9109, TaKaRa); HiScript III RT SuperMix (R323, Vazyme); SYBR Green Supermix (Q312, Vazyme); Lipofectamine 3000 (L3000015, Invitrogen); FuGENE HD (E2311, Promega); EZ-Link Sulfo-NHS-SS-Biotin (A39258, Thermo); streptavidin agarose (P2159, Beyotime); endoglycosidase H (P0702S, NEB); protein A+G agarose (P2055, Beyotime); and the inhibitors brefeldin A, aprotinin, leupeptin, β-glycerophosphate, and sodium orthovanadate (MCE). .. Antibodies used were anti-HA (H6908, Sigma); anti-Flag (F3165, Sigma); HRP-Flag (ZB15939, Servicebio); mouse and rabbit IgG controls (I5381, I5006, Sigma); anti-mouse IgG (H+L), Alexa Fluor 594 (8890, CST); anti-rabbit IgG (H+L), AF647 (A0468, Beyotime); DAPI (S36920, Thermo); APC-conjugated HLA-ABC (17-9983-42), CD4 (17-0042-82), and CD8a (17-0081-82), FITC-conjugated HLA-ABC (11-9983-42), CD71 (11-0719-42), CD3e (11-0031-82), and PE-conjugated IFN-γ (12-7311-82) (all from eBioscience); FITC-con jugated CD46 (MA1-19601, Invitrogen); HLA class I ABC (15240-1-AP, Proteintech); GFP (66002-1-Ig, Proteintech); ATP1A1 (14418-1-AP, Proteintech); CD28 (16-0281-82, eBioscience); GAPDH (60004-1-Ig, Proteintech); and β-actin (sc-47778, Santa Cruz Biotechnology).

    Cytometry:

    Article Title: The lumpy skin disease virus protein LSDV003 regulates MHC-I trafficking and surface expression.
    Article Snippet: .. Reagents included TrypLE Express (12604021, ThermoFisher Scientific); EDTA (10 mM, pH 8.0; BL518A, Biosharp); Flow Cytometry Perm Buffer (PF00017, Proteintech); RNAiso Plus (#9109, TaKaRa); HiScript III RT SuperMix (R323, Vazyme); SYBR Green Supermix (Q312, Vazyme); Lipofectamine 3000 (L3000015, Invitrogen); FuGENE HD (E2311, Promega); EZ-Link Sulfo-NHS-SS-Biotin (A39258, Thermo); streptavidin agarose (P2159, Beyotime); endoglycosidase H (P0702S, NEB); protein A+G agarose (P2055, Beyotime); and the inhibitors brefeldin A, aprotinin, leupeptin, β-glycerophosphate, and sodium orthovanadate (MCE). .. Antibodies used were anti-HA (H6908, Sigma); anti-Flag (F3165, Sigma); HRP-Flag (ZB15939, Servicebio); mouse and rabbit IgG controls (I5381, I5006, Sigma); anti-mouse IgG (H+L), Alexa Fluor 594 (8890, CST); anti-rabbit IgG (H+L), AF647 (A0468, Beyotime); DAPI (S36920, Thermo); APC-conjugated HLA-ABC (17-9983-42), CD4 (17-0042-82), and CD8a (17-0081-82), FITC-conjugated HLA-ABC (11-9983-42), CD71 (11-0719-42), CD3e (11-0031-82), and PE-conjugated IFN-γ (12-7311-82) (all from eBioscience); FITC-con jugated CD46 (MA1-19601, Invitrogen); HLA class I ABC (15240-1-AP, Proteintech); GFP (66002-1-Ig, Proteintech); ATP1A1 (14418-1-AP, Proteintech); CD28 (16-0281-82, eBioscience); GAPDH (60004-1-Ig, Proteintech); and β-actin (sc-47778, Santa Cruz Biotechnology).

    SYBR Green Assay:

    Article Title: The lumpy skin disease virus protein LSDV003 regulates MHC-I trafficking and surface expression.
    Article Snippet: .. Reagents included TrypLE Express (12604021, ThermoFisher Scientific); EDTA (10 mM, pH 8.0; BL518A, Biosharp); Flow Cytometry Perm Buffer (PF00017, Proteintech); RNAiso Plus (#9109, TaKaRa); HiScript III RT SuperMix (R323, Vazyme); SYBR Green Supermix (Q312, Vazyme); Lipofectamine 3000 (L3000015, Invitrogen); FuGENE HD (E2311, Promega); EZ-Link Sulfo-NHS-SS-Biotin (A39258, Thermo); streptavidin agarose (P2159, Beyotime); endoglycosidase H (P0702S, NEB); protein A+G agarose (P2055, Beyotime); and the inhibitors brefeldin A, aprotinin, leupeptin, β-glycerophosphate, and sodium orthovanadate (MCE). .. Antibodies used were anti-HA (H6908, Sigma); anti-Flag (F3165, Sigma); HRP-Flag (ZB15939, Servicebio); mouse and rabbit IgG controls (I5381, I5006, Sigma); anti-mouse IgG (H+L), Alexa Fluor 594 (8890, CST); anti-rabbit IgG (H+L), AF647 (A0468, Beyotime); DAPI (S36920, Thermo); APC-conjugated HLA-ABC (17-9983-42), CD4 (17-0042-82), and CD8a (17-0081-82), FITC-conjugated HLA-ABC (11-9983-42), CD71 (11-0719-42), CD3e (11-0031-82), and PE-conjugated IFN-γ (12-7311-82) (all from eBioscience); FITC-con jugated CD46 (MA1-19601, Invitrogen); HLA class I ABC (15240-1-AP, Proteintech); GFP (66002-1-Ig, Proteintech); ATP1A1 (14418-1-AP, Proteintech); CD28 (16-0281-82, eBioscience); GAPDH (60004-1-Ig, Proteintech); and β-actin (sc-47778, Santa Cruz Biotechnology).



    Similar Products

    95
    MedChemExpress ferric ammonium citrate fac
    (A) Glioma cell survival at 24 h after SS treatment. (B) Glioma cell survival after pretreatment with <t>DFO,</t> <t>FAC,</t> Fer‐1, and Lip‐1, respectively, for 1 h before SS treatment. (C–F) Intracellular ROS, MDA, GSH/GSSG, and ferrous ion levels at 6, 12, and 24 h after SS treatment, with and without DFO, Fer‐1, Lip‐1, and FAC pretreatment for 1 h before SS treatment, respectively. (G) Glioma cell survival after SS treatment, with and without pretreatment with NAC and GSH for 1 h before SS treatment, respectively. (H) Western blots of ferroptosis‐related protein expression after SS treatment. Cell survival was assessed by the CCK‐8 assay. (I) Western blots of ATF3 expression in the cytoplasm and nuclei of SS‐treated cells. (J) Viability of cells treated with siATF3 followed by SS. (K–N) Ferrous ion, MDA, GSH/GSSG, and ROS levels in cells treated with siATF3 followed by SS. (O) Confocal microscopic images of ATF3 immunofluorescence in U251 cells treated with SS. (P, Q) Confocal microscopy images and fluorescence intensity measurements of mitochondrial superoxide in SS‐ and siATF3‐treated U251 and T98 cells. * p < 0.01 versus control, # p < 0.01 versus treatment group.
    Ferric Ammonium Citrate Fac, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/iii/Ammonium+iron(III)+citrate/pmc13695081-47-4-32
    Average 95 stars, based on 1 article reviews
    ferric ammonium citrate fac - by Bioz Stars, 2026-11
    95/100 stars
      Buy from Supplier

    99
    Vazyme Biotech Co hiscript iii rt supermix for qpcr
    (A) Glioma cell survival at 24 h after SS treatment. (B) Glioma cell survival after pretreatment with <t>DFO,</t> <t>FAC,</t> Fer‐1, and Lip‐1, respectively, for 1 h before SS treatment. (C–F) Intracellular ROS, MDA, GSH/GSSG, and ferrous ion levels at 6, 12, and 24 h after SS treatment, with and without DFO, Fer‐1, Lip‐1, and FAC pretreatment for 1 h before SS treatment, respectively. (G) Glioma cell survival after SS treatment, with and without pretreatment with NAC and GSH for 1 h before SS treatment, respectively. (H) Western blots of ferroptosis‐related protein expression after SS treatment. Cell survival was assessed by the CCK‐8 assay. (I) Western blots of ATF3 expression in the cytoplasm and nuclei of SS‐treated cells. (J) Viability of cells treated with siATF3 followed by SS. (K–N) Ferrous ion, MDA, GSH/GSSG, and ROS levels in cells treated with siATF3 followed by SS. (O) Confocal microscopic images of ATF3 immunofluorescence in U251 cells treated with SS. (P, Q) Confocal microscopy images and fluorescence intensity measurements of mitochondrial superoxide in SS‐ and siATF3‐treated U251 and T98 cells. * p < 0.01 versus control, # p < 0.01 versus treatment group.
    Hiscript Iii Rt Supermix For Qpcr, supplied by Vazyme Biotech Co, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/iii/HiScript+III+RT+SuperMix+for+qPCR+%2BgDNA+wiper/pm42908380-364-14-22
    Average 99 stars, based on 1 article reviews
    hiscript iii rt supermix for qpcr - by Bioz Stars, 2026-11
    99/100 stars
      Buy from Supplier

    96
    Revvity ivis optical imaging platform
    (A) Glioma cell survival at 24 h after SS treatment. (B) Glioma cell survival after pretreatment with <t>DFO,</t> <t>FAC,</t> Fer‐1, and Lip‐1, respectively, for 1 h before SS treatment. (C–F) Intracellular ROS, MDA, GSH/GSSG, and ferrous ion levels at 6, 12, and 24 h after SS treatment, with and without DFO, Fer‐1, Lip‐1, and FAC pretreatment for 1 h before SS treatment, respectively. (G) Glioma cell survival after SS treatment, with and without pretreatment with NAC and GSH for 1 h before SS treatment, respectively. (H) Western blots of ferroptosis‐related protein expression after SS treatment. Cell survival was assessed by the CCK‐8 assay. (I) Western blots of ATF3 expression in the cytoplasm and nuclei of SS‐treated cells. (J) Viability of cells treated with siATF3 followed by SS. (K–N) Ferrous ion, MDA, GSH/GSSG, and ROS levels in cells treated with siATF3 followed by SS. (O) Confocal microscopic images of ATF3 immunofluorescence in U251 cells treated with SS. (P, Q) Confocal microscopy images and fluorescence intensity measurements of mitochondrial superoxide in SS‐ and siATF3‐treated U251 and T98 cells. * p < 0.01 versus control, # p < 0.01 versus treatment group.
    Ivis Optical Imaging Platform, supplied by Revvity, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/iii/IVIS+optical+imaging+platform/custom%40cls158738%4042976903
    Average 96 stars, based on 1 article reviews
    ivis optical imaging platform - by Bioz Stars, 2026-11
    96/100 stars
      Buy from Supplier

    86
    Instron Corp groups three point
    (A) Glioma cell survival at 24 h after SS treatment. (B) Glioma cell survival after pretreatment with <t>DFO,</t> <t>FAC,</t> Fer‐1, and Lip‐1, respectively, for 1 h before SS treatment. (C–F) Intracellular ROS, MDA, GSH/GSSG, and ferrous ion levels at 6, 12, and 24 h after SS treatment, with and without DFO, Fer‐1, Lip‐1, and FAC pretreatment for 1 h before SS treatment, respectively. (G) Glioma cell survival after SS treatment, with and without pretreatment with NAC and GSH for 1 h before SS treatment, respectively. (H) Western blots of ferroptosis‐related protein expression after SS treatment. Cell survival was assessed by the CCK‐8 assay. (I) Western blots of ATF3 expression in the cytoplasm and nuclei of SS‐treated cells. (J) Viability of cells treated with siATF3 followed by SS. (K–N) Ferrous ion, MDA, GSH/GSSG, and ROS levels in cells treated with siATF3 followed by SS. (O) Confocal microscopic images of ATF3 immunofluorescence in U251 cells treated with SS. (P, Q) Confocal microscopy images and fluorescence intensity measurements of mitochondrial superoxide in SS‐ and siATF3‐treated U251 and T98 cells. * p < 0.01 versus control, # p < 0.01 versus treatment group.
    Groups Three Point, supplied by Instron Corp, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/iii/bending+point+tester+three/pmc13251218-426-13-18
    Average 86 stars, based on 1 article reviews
    groups three point - by Bioz Stars, 2026-11
    86/100 stars
      Buy from Supplier

    99
    Vazyme Biotech Co hiscript iii qrt supermix
    (A) Glioma cell survival at 24 h after SS treatment. (B) Glioma cell survival after pretreatment with <t>DFO,</t> <t>FAC,</t> Fer‐1, and Lip‐1, respectively, for 1 h before SS treatment. (C–F) Intracellular ROS, MDA, GSH/GSSG, and ferrous ion levels at 6, 12, and 24 h after SS treatment, with and without DFO, Fer‐1, Lip‐1, and FAC pretreatment for 1 h before SS treatment, respectively. (G) Glioma cell survival after SS treatment, with and without pretreatment with NAC and GSH for 1 h before SS treatment, respectively. (H) Western blots of ferroptosis‐related protein expression after SS treatment. Cell survival was assessed by the CCK‐8 assay. (I) Western blots of ATF3 expression in the cytoplasm and nuclei of SS‐treated cells. (J) Viability of cells treated with siATF3 followed by SS. (K–N) Ferrous ion, MDA, GSH/GSSG, and ROS levels in cells treated with siATF3 followed by SS. (O) Confocal microscopic images of ATF3 immunofluorescence in U251 cells treated with SS. (P, Q) Confocal microscopy images and fluorescence intensity measurements of mitochondrial superoxide in SS‐ and siATF3‐treated U251 and T98 cells. * p < 0.01 versus control, # p < 0.01 versus treatment group.
    Hiscript Iii Qrt Supermix, supplied by Vazyme Biotech Co, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/iii/HiScript+IV+All-in-One+Ultra+RT+SuperMix+for+qPCR/pm42914648-95-14-19
    Average 99 stars, based on 1 article reviews
    hiscript iii qrt supermix - by Bioz Stars, 2026-11
    99/100 stars
      Buy from Supplier

    99
    Vazyme Biotech Co hiscript iii rt supermix
    (A) Glioma cell survival at 24 h after SS treatment. (B) Glioma cell survival after pretreatment with <t>DFO,</t> <t>FAC,</t> Fer‐1, and Lip‐1, respectively, for 1 h before SS treatment. (C–F) Intracellular ROS, MDA, GSH/GSSG, and ferrous ion levels at 6, 12, and 24 h after SS treatment, with and without DFO, Fer‐1, Lip‐1, and FAC pretreatment for 1 h before SS treatment, respectively. (G) Glioma cell survival after SS treatment, with and without pretreatment with NAC and GSH for 1 h before SS treatment, respectively. (H) Western blots of ferroptosis‐related protein expression after SS treatment. Cell survival was assessed by the CCK‐8 assay. (I) Western blots of ATF3 expression in the cytoplasm and nuclei of SS‐treated cells. (J) Viability of cells treated with siATF3 followed by SS. (K–N) Ferrous ion, MDA, GSH/GSSG, and ROS levels in cells treated with siATF3 followed by SS. (O) Confocal microscopic images of ATF3 immunofluorescence in U251 cells treated with SS. (P, Q) Confocal microscopy images and fluorescence intensity measurements of mitochondrial superoxide in SS‐ and siATF3‐treated U251 and T98 cells. * p < 0.01 versus control, # p < 0.01 versus treatment group.
    Hiscript Iii Rt Supermix, supplied by Vazyme Biotech Co, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/iii/HiScript+III+RT+SuperMix+for+qPCR+%2BgDNA+wiper/pm42910938-259-24-29
    Average 99 stars, based on 1 article reviews
    hiscript iii rt supermix - by Bioz Stars, 2026-11
    99/100 stars
      Buy from Supplier

    99
    Vazyme Biotech Co hiscript iii all
    (A) Glioma cell survival at 24 h after SS treatment. (B) Glioma cell survival after pretreatment with <t>DFO,</t> <t>FAC,</t> Fer‐1, and Lip‐1, respectively, for 1 h before SS treatment. (C–F) Intracellular ROS, MDA, GSH/GSSG, and ferrous ion levels at 6, 12, and 24 h after SS treatment, with and without DFO, Fer‐1, Lip‐1, and FAC pretreatment for 1 h before SS treatment, respectively. (G) Glioma cell survival after SS treatment, with and without pretreatment with NAC and GSH for 1 h before SS treatment, respectively. (H) Western blots of ferroptosis‐related protein expression after SS treatment. Cell survival was assessed by the CCK‐8 assay. (I) Western blots of ATF3 expression in the cytoplasm and nuclei of SS‐treated cells. (J) Viability of cells treated with siATF3 followed by SS. (K–N) Ferrous ion, MDA, GSH/GSSG, and ROS levels in cells treated with siATF3 followed by SS. (O) Confocal microscopic images of ATF3 immunofluorescence in U251 cells treated with SS. (P, Q) Confocal microscopy images and fluorescence intensity measurements of mitochondrial superoxide in SS‐ and siATF3‐treated U251 and T98 cells. * p < 0.01 versus control, # p < 0.01 versus treatment group.
    Hiscript Iii All, supplied by Vazyme Biotech Co, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/iii/HiScript+III+All-in-one+RT+SuperMix+Perfect+for+qPCR/pm42905834-304-4-12
    Average 99 stars, based on 1 article reviews
    hiscript iii all - by Bioz Stars, 2026-11
    99/100 stars
      Buy from Supplier

    Image Search Results


    (A) Glioma cell survival at 24 h after SS treatment. (B) Glioma cell survival after pretreatment with DFO, FAC, Fer‐1, and Lip‐1, respectively, for 1 h before SS treatment. (C–F) Intracellular ROS, MDA, GSH/GSSG, and ferrous ion levels at 6, 12, and 24 h after SS treatment, with and without DFO, Fer‐1, Lip‐1, and FAC pretreatment for 1 h before SS treatment, respectively. (G) Glioma cell survival after SS treatment, with and without pretreatment with NAC and GSH for 1 h before SS treatment, respectively. (H) Western blots of ferroptosis‐related protein expression after SS treatment. Cell survival was assessed by the CCK‐8 assay. (I) Western blots of ATF3 expression in the cytoplasm and nuclei of SS‐treated cells. (J) Viability of cells treated with siATF3 followed by SS. (K–N) Ferrous ion, MDA, GSH/GSSG, and ROS levels in cells treated with siATF3 followed by SS. (O) Confocal microscopic images of ATF3 immunofluorescence in U251 cells treated with SS. (P, Q) Confocal microscopy images and fluorescence intensity measurements of mitochondrial superoxide in SS‐ and siATF3‐treated U251 and T98 cells. * p < 0.01 versus control, # p < 0.01 versus treatment group.

    Journal: CNS Neuroscience & Therapeutics

    Article Title: ATF3 Promotes Solasonine‐Triggered Ferroptosis in Glioma Cells by Suppressing Glycolysis

    doi: 10.1002/cns.71226

    Figure Lengend Snippet: (A) Glioma cell survival at 24 h after SS treatment. (B) Glioma cell survival after pretreatment with DFO, FAC, Fer‐1, and Lip‐1, respectively, for 1 h before SS treatment. (C–F) Intracellular ROS, MDA, GSH/GSSG, and ferrous ion levels at 6, 12, and 24 h after SS treatment, with and without DFO, Fer‐1, Lip‐1, and FAC pretreatment for 1 h before SS treatment, respectively. (G) Glioma cell survival after SS treatment, with and without pretreatment with NAC and GSH for 1 h before SS treatment, respectively. (H) Western blots of ferroptosis‐related protein expression after SS treatment. Cell survival was assessed by the CCK‐8 assay. (I) Western blots of ATF3 expression in the cytoplasm and nuclei of SS‐treated cells. (J) Viability of cells treated with siATF3 followed by SS. (K–N) Ferrous ion, MDA, GSH/GSSG, and ROS levels in cells treated with siATF3 followed by SS. (O) Confocal microscopic images of ATF3 immunofluorescence in U251 cells treated with SS. (P, Q) Confocal microscopy images and fluorescence intensity measurements of mitochondrial superoxide in SS‐ and siATF3‐treated U251 and T98 cells. * p < 0.01 versus control, # p < 0.01 versus treatment group.

    Article Snippet: Ferrostatin‐1 (Fer‐1), deferoxamine (DFO), ferric ammonium citrate (FAC), liproxstatin‐1 (Lip‐1), adenosine triphosphate (ATP), bafilomycin A1 (Baf‐A1), 3‐methyladenine (3MA), N‐acetylcysteine (NAC), reduced L‐glutathione (GSH), sodium 4‐phenylbutyrate (4‐PBA), and sodium 2‐oxopropanoate were purchased from MedChemExpress (NJ, USA).

    Techniques: Western Blot, Expressing, CCK-8 Assay, Confocal, Immunofluorescence, Microscopy, Fluorescence, Control